Iridex Corp (IRIX)
Iridex Corporation (IRIX) is a medical device company specializing in ophthalmic surgical and laser therapy systems. Founded in 1984, the company develops innovative laser products for the treatment of ocular diseases, primarily focusing on minimally invasive procedures for conditions such as glaucoma, retinal therapy, and diabetic retinopathy. Iridex's products are used by ophthalmologists worldwide to improve patient outcomes through precise and effective laser treatments.
Company News
Medical device company Iridex reported Q2 2025 results with modest revenue growth, narrower net loss, and positive adjusted EBITDA, driven by cost control and operational discipline.
Iridex Corporation, a leader in laser-based medical systems for ophthalmology, commented on recent stock price volatility, stating that there have been no material changes to its operating or financial condition.
Iridex (IRIX) delivered earnings and revenue surprises of -75% and 1.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision. The Dow traded up 0.40% to 33,185.41 while the NASDAQ rose 0.92% to 12,969.54. The S&P 500 also rose, gaining, 0.67% to 4,221.94. Check This Out: $2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying  Leadin...